2nd July
SYMPATHETIC ACTIVITY AND ARTERIAL HYPERTENSION
CORONARY PHYSIOLOGY IN THE CATH LAB. NEW TOOLS FOR THE DIAGNOSIS
HEART FAILURE. ANTEVISION OF NEW GUIDELINES
ACUTE CORONARY SYNDROMES IN TIMES OF COVID-19
3rd July
DRUGS & DEVICES FOR THE TREATMENT OF HFPEF – THE 2021 APPROACH
CLINICAL MANAGEMENT OF HYPERKALIEMIA. THE ROLE OF PATIROMER
DYSLIPIDEMIA IN DIABETIC PATIENTS. WHY IS DIFFERENT AND HOW TO TREAT?
AN OVERVIEW ON CHRONIC CORONARY SYNDROMES
CHRONIC CORONARY SYNDROMES. LESSONS FROM CLINICAL CASES
9th July
NEW TREATMENTS FOR DYSLIPIDEMIA IN A PERSONALIZED MEDICINE ERA – BEMPEDOIC ACID
HEART FAILURE GUIDELINES: SACUBITRIL/VALSARTAN IN THE FIRST-LINE OF HF-REF TREATMENT - FROM RATIONALE TO CLINICAL PRATICE
DUAL PATHWAY THROMBOTIC INHIBITION. A NEW AVENUE FOR CHRONIC ATHEROSCLEROSIS
IS THERE A HIDDEN KILLER IN YOUR PATIENT WITH HEART FAILURE?
10th July
BENEFICIAL EFFECTS OF LONG-TERM INTRAVENOUS IRON THERAPY IN PATIENTS WITH HEART FAILURE
SUDDEN DEATH IN THE YOUNGS
VERICIGUAT: A NEW PHARMACOLOGICAL OPTION TO REDUCE THE BURDEN OF HFREF
NEWS ON CARDIAC PACING
GOLDEN SESSION
MEDIA - O FUTURO DA FORMAÇÃO MÉDICA PÓS-GRADUADA EM PORTUGAL
MEDIA - O FUTURO DA FORMAÇÃO MÉDICA PÓS-GRADUADA EM PORTUGAL